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Abstract: Hyperbranched polyglycerol (hPG) has been used as a multivalent scaffold to develop
a series of nanocarriers capable of high-affinity encapsulation of copper (Cu). A rationally selected
set of Cu-complexing motifs has been conjugated to hPG hydroxyl groups to render the constructs
potentially usable as exogenous sources of Cu for addressing different pathological conditions
associated with Cu-deficiency. We have utilized a newly discovered route to attach Cu-binding
domains exclusively within a hPG core by selective differentiation between the primary and secondary
hydroxyl groups of the polyol. These hPG-derivatives were found to form a stable complex with Cu
ions depending on the type of immobilized ligands and corresponding degree of functionalization.
In addition, these Cu-bearing nano-complexes demonstrated moderately cationic surface charge
resulting in adjustable protein-binding characteristics and low cellular toxicity profile. We envision
that these Cu-loaded hPG nanocarriers can be used as a stable platform to transport the metal ion
across the systemic circulation to supply bioavailable quantity of Cu in disease-afflicted tissues.
Keywords: hyperbranched polyglycerol; nanocarrier; ion transport; Cu-deficiency disorders
1. Introduction
Recapitulation of homeostatic level of electrolytes or trace element concentration is one of the
mainstays of clinical management for a number of pathological conditions, including but not limited to
blood disorders, renal failure, acute poisoning, cancer and skeletal system-related diseases. In biological
systems, Cu ions are cofactors of several metalloenzymes and are essential for central nervous system
(CNS) development [1–4]. For example, alterations in Cu balance have been linked, but not causally
associated, to changes in senile plaque deposition in Alzheimer’s disease (AD) [5]. Currently in clinical
trials, exogenous supply of Cu is mediated by soluble oral administration of soluble metal salts or
metal complexes in disease conditions where Cu supplementation is required. For example, potential
beneficial effects of oral intake of Cu (II)-orotate-dihydrate (8 mg Cu daily) were investigated in AD
patients. Although results demonstrated that oral Cu intake has neither a detrimental nor a promoting
effect on the progression of AD, Cu treatment stabilized plasma and CSF levels in AD patients and
antagonized the unbalanced Cu levels likely by activating the homeostatic system [6,7]. Studies
with the antibiotic clioquinol (CQ), an 8-OH quinoline with a moderate affinity for Cu2+ and Zn2+,
the lipophilic chelator (DP109), isatin-Schiff base Cu (II)-complexes and metal bis(thiosemicarbazonato)
complexes also confirmed that promoting Cu uptake is a reasonable treatment strategy [8–11] in
Cu deficiency-related disorders. To offset the obvious pharmacokinetic challenges involved with
these monovalent, small molecular Cu complexing agents pertaining to systemic toxicity due to
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complex instability, bioavailability, circulation lifetime and dosing frequency, we have reported a library
of macromolecular, multivalent, Cu-encapsulating nanocarrier platforms based on hyperbranched
polyglycerol (hPG) [12–14]. Due to the presence of multiple chemically accessible hydroxyl groups
and very stable ether backbone, as well as high compatibility, we found hPG as an ideal candidate
to design Cu complexing systems for therapeutic use. Previously, we showed that the presence of
multivalent Cu-complexing ligands on a hPG platform not only increased the affinity and stability of
the ligands towards the metal ion, but also suppressed the risk of non-specific toxicity due to premature
leaching of the metal ion from the complex. In addition, the synthesized hPG-derived Cu-nanocarriers
showed permeation through human brain microvascular endothelial cell (HBMEC) model, which was
established to investigate the engagement of these nanocarriers through the blood brain barrier (BBB).
It was shown that, hPG-based nanocarriers crossed the BBB model two times more effectively than
14C-sucrose and sodium fluorescein (NaFl) and up to 60× better than Evans Blue labeled albumin
(EBA), when the the permeability × surface area product (PSe) of the nanocarrier and reference
substances were compared [13]. As a polyether, hPG contains a large number of C-O bonds and
hydroxyl groups, which makes the molecule highly hydrophilic. In addition, these polyether-based
multi-functional scaffolds exhibited condensed three-dimensional structure with a hydrodynamic
diameter typically within the range of 3–5 nm, high Cu-loading capacity, intracellular transport
and inertness to ubiquitous biological components such as protein and phospholipid membranes.
In this study, we elaborate the potential routes to generate hPG-scaffolds, which either complex Cu
within a specific molecular domain, or, are decorated with ligands that can either impart superior
biocompatibility and putative receptor engagement. The designed architectures were tested for
formation of the metal-complex and thermodynamics of the complex stabilization. In addition,
we have also investigated electrostatic and surface properties of these dendritic nano-constructs,
and evaluated their cellular toxicity and uptake behavior in mammalian cell lines.
2. Results
Compared to linear polymers of analogous molecular weight, spatially globular architecture of
hPGs gives rise to a number of interesting properties such as reduced viscosities and enhanced water
solubility, both of which can be readily modulated by post-synthetic functionalization of peripheral
hydroxyl functional group through classical alcohol-group chemistry [15–21]. Another salient feature
that makes hPGs unique from its linear analogues is the fact that these macromolecules exhibit
a distinct, convertible ‘interior’ supramolecular space [22], sterically shielded from the topological
‘exterior’ of the scaffold (Scheme 1) [23].
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Scheme 1. Representative illustration of interior and exterior of hPG (1a) scaffold has been indicated
by the blue and brown shaded spheres respectively. In structure (1b), the interior hydroxyl groups
have been converted to amines.
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We set out to modify the hPG core structure by orthogonally including/attaching: (a) a Cu
encapsulating domain at a specific location within the molecule that can potentially complex Cu ion
with substantial stability; and (b) a molecular species that can putatively suppress cytotoxicity and
mediate cellular entry. Cu complexing nanocarriers designed in this study are presented in Table 1.
We optimized the synthetic design of these hPG-derived metal ion nanocarriers and investigated their
capacity to interact with Cu-ion in physiological settings.
Table 1. Library of hPG-based Cu-complexing nanocarriers. * Compound 3f indicates TMEDA bearing
hPG systems at full functionalization level. Synthesis and characterization of compound 3f (at full
functionalization level) has been reported earlier [13]. Different partial functionalization of hPG,
wherever used in this study, has been specified accordingly.
Compoundno. Compound Code Structure
Molecules 2018, 23, x FOR PEER REVIEW  3 of 26 
 
Scheme 1. Representative illustration of interior and exterior of hPG (1a) scaffold has been indicated 
by the blue and brown shaded spheres respectively. In structure (1b), the interior hydroxyl groups 
have been converted to amines. 
We set out to modify the hPG core structure by orthogonally including/attaching: (a) a Cu 
encapsulating domain at a specific location within the molecule that can potentially complex Cu ion 
with substantial stability; and (b) a molecular species that can putatively suppress cytotoxicity and 
mediate cellular entry. Cu complexing nanocarriers designed in this study are presented in Table 1. 
We optimized the synthetic design of these hPG-derived metal ion nanocarriers and investigated 
their capacity to interact with Cu-ion in physiological settings. 
Table 1. Library of hPG-based Cu-complexing nanocarriers. * Compound 3f indicates TMEDA 
bearing hPG systems at full functionalization level. Synthesis and characterization of compound 3f 
(at full functionalization level) has been reported earlier [13]. Different partial functionalization of 
hPG, wherever used in this study, has been specified accordingly. 
Compoundno. Compound Code Structure 
   
  
 
3a PG10-DMA R1 = R2 = -CH3 
3b PG10-DEA R1 = R2 = -CH2-CH3 
3c PG10-DPA R1 = R2 = -CH2-CH2-CH3 
3d PG10-DIPA R1 = R2 = -CH(CH3)2 
3e PG10-DBA R1 = R2 = -CH2-CH2-CH2-CH3 
3f * PG10-(TMEDA)x 
 
X = Degree of functionalization, for 3f, X = 1.0 
8 PGm-cNH2 
 
8a m = 10 kDa 





3a PG10-DMA R1 = R2 = -CH3
3b PG10-DEA R1 = R2 = -CH2-CH3
3c PG10-DPA R1 = R2 = -CH2-CH2-CH3
3d PG10-DIPA R1 = R2 = -CH(CH3)2
3e PG10-DBA R1 = R2 = -CH2-CH2-CH2-CH3
3f * PG10-(TMEDA)x
Molecules 2018, 23, x FOR PEER REVIEW 3 of 26 
Scheme 1. Representative illustration of interior and exterior of hPG (1a) scaffold has been indicated 
by the blue and brown shaded spheres respectively. In structure (1b), the interior hydroxyl groups 
have been converted to amines. 
We set out to modify the hPG core structure by orthogonally including/attaching: (a) a Cu 
encapsulating domain at a specific location within the molecule that can potentially complex Cu ion 
with substantial stability; and (b) a molecular species that can putatively suppress cytotoxicity and 
mediate cellular entry. Cu complexing nanocarriers designed in this study are presented in Table 1. 
We optimized the synthetic design of these hPG-derived metal ion nanocarriers and investigated 
their c pacity to interact with Cu-ion in physiological settings. 
Table 1. Library of hPG-based Cu-complexing nanocarriers. * Compound 3f indicates TMEDA 
bearing hPG systems at full functionalization level. Synthesis and characterization of compound 3f 
(at full functionalization level) has been reported earlier [13]. Different partial functionalization of 
hPG, wherever used in this study, has been specified accordingly. 
Compoundno. Compound Code Structure 
3a P 10- M  1 = R2 = - 3 
3b 10- E  1 = 2 = - 2-CH3 
c 10- P  R1 = R2 = -CH2-CH2-CH3 
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Table 1. Cont.
Compoundno. Compound Code Structure
12 PG10-KR455
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The critical consideration in this reaction is the high volatility of dialkylamines and the
requirement of relatively high temperature (over 100 ◦C) to carry out the reaction. We have synthesized
a series of dialkylamine-substituted hPG following this reaction protocol with satisfactory yield as
presented in Table 2.
Table 2. Designing dialkylamine terminated PG. Range of amine groups and yields. Compound 3f has
not been included, as chemical data of the molecule has been published earlier [13].






Figure 1 shows the 1H-NMR spectrum of 3b. The broadened signals of the protons of CH3 at
1.31 ppm and CH2 group from 2.32–2.81 ppm indicate the immobilization of dialkylamine moiety onto
the PG scaffold. The degree of functionalization can be estimated from relative integration intensities
of the signals from CH3 group and that from PG scaffold (3.5–4.0 ppm). In the case of compounds 3c
to 3e, the degree of functionalization could be easily determined by considering the terminal methyl
proton as a reference for calculation. A full synthesis, chemical and biochemical characterization of
compound 3f has been published earlier [13]. Hence, limited experimental data has been presented
for this compound for comparison purpose, while, synthetic, UV-spectroscopic, calorimetric and cell
cytotoxicity experiment has been conducted and presented for other Cu-nanocarrier candidates.
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Figure 1. 1H-NMR of diethylamine functionalized PG (3b) at quantitative functionalization level.
This is noteworthy that since the signals due to the protons belonging to the alkyl chain of
dialkylamines, which are located next to nitrogen atom, overlap with PG signal, therefore the area
corresponding to two protons should be subtracted from the PG signal integration to avoid the
underestimation of the actual degree of functionalization. The absence of a signal at 3.12 ppm indicates
the complete removal o the mesyl group from the PG backbone. Similar 1H-NMR patterns were
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observed with other secondary dialkylamines attached to PG. 13C-NMR and IR spectra were also
found to be confirmatory for the proposed product structures.
2.2. Selective Chemical Differentiation of Primary and Secondary Hydroxyl Groups of hPG: Cu-Binding
Domains at hPG Core
In contrast to dendrimers, hyperbranched polymers showed no distinguishable interior and
periphery. Hyperbranched PGs, however, possesses two types of hydroxyl functional groups
(generated from linear and terminal glycerol units), which can be chemically differentiated [24].
Although the linear units are randomly dispersed throughout the structure, they are predominantly
present in the proximity of the focal or “core” unit of the macromolecule, when the polymers are
prepared by slow monomer addition technique [25]. By following an earlier procedure developed by
Haag et al. [22], a chemical differentiation strategy has been undertaken to synthesize core-aminated
PG where the “focal-close” linear hydroxyl groups were selectively converted to amines keeping the
terminal hydroxyl groups intact. These structural variants of PG were envisioned to encapsulate
Cu ion through the nitrogen atoms present in the core, thereby shielding the encapsulation zone.
With such structures, it was also possible to retain the required water solubility and biocompatibility
profile of the complexes, which are mostly contributed through the “focal-distant” terminal hydroxyl
groups. These hyperbranched scaffolds could be envisioned as the molecular chaperons observed
in biological systems where the guest molecule is shielded from external environment. The outer
hydroxyl group can further be functionalized with targeting moieties or biocompatible PEG shells.
In the first step to construct this type of architecture, the terminal 1,2-diols of PG were regioselectively
converted to polyacetal 4. The complete conversion of 1,2-diols in PG was observed (according to
13C- and 1H-NMR) leaving approximately 40% of the hydroxyl groups unaffected [22]. The synthetic
scheme of core-functionalized polyglycerolamine is presented in Scheme 3.
Scheme 3. Synthesis of core-functionalized polyglycerolamine 8.
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The conversion of 5 from 4 could be monitored by means of IR, by tracking the appearance of
azide signal (at 2100 cm−1) in polyglycerol azide, 6 [15]. Deprotection of acetals was carried out in the
following step with acidic Dowex-400 resin, where the selective acid-catalyzed cleavage of the acetal
groups proceeded with quantitative conversion yielding 7. Core functionalized polyglycerolazide
7 synthesized in this way, where the azide groups are located only at the core of the hyperbranched
molecule could also be envisioned as an useful substrate for metal assisted 1,3-Huisgen type “click”
chemistry approach. Staudinger reduction of core-functionalized polyglycerolazide carried out in
the presence of triphenylphosphine and water, yielded core-functionalized polyglycerolamine (8),
as confirmed by complete elimination of azide signal in IR spectra. Usually Staudinger reaction is
carried out in THF in the presence of small amount of water (5%). However, this is to note that, careful
consideration is needed to maintain the ratio of THF to water during the course of the reaction, so that
premature precipitation of compound 7 can be optimally minimized.
2.3. Amide Coupling for the Synthesis of hPG-Bispicolylamide Derivatives
Cu2+ complexation of a bispicolylamide entity is a widely studied phenomena in designing linker
molecules for solid phase peptide synthesis [26]. In peptide chemistry, this type of complexation leads
to a weakening of the N-C-amide bond, which can subsequently be cleaved under very mild condition
by methanolysis [27–29]. In nature, metalloproteases use the same mechanism for hydrolytic cleavage
of the peptide bond. Due to high affinity complexation capacity of bispicolylamide derivatives towards
Cu, we hypothesized that, bispicolylamide derivatives bound to PG by a stable amide linkage will
encapsulate Cu2+ ion in aqueous environment with substantial stability. Therefore two carboxylic acid
terminated bispicolylamide derivatives, namely NF 135 and KR 455 (a kind gift from AG Bannawarth,
Universität Freiburg, Freiburg, Germany) were coupled to core-aminated PG through an amide
bond formation to synthesize compounds 11 and 12, respectively. These derivatives were coupled
to core-aminated PG, (8, PG10-cNH2) by EDCI/DMAP mediated coupling protocol. An overnight
dialysis in methanol yielded pure compounds 11 and 12 in quantitative yield. 1H-NMR conclusively
proved the immobilization of the derivatives on to PG scaffold where the broadened signals of protons
from the BOC group and those from aromatic pyridine moiety resonate around 1.39 ppm and from 7.0
to 8.57 ppm respectively. Degree of functionalization was limited to approximately 20% in both cases
compared to all hydroxyl groups of PG to ensure water-solubility of the products.
2.4. Reductive Amination Pathway towards the Synthesis of Mono-and Oligosaccharide Modified hPG-Amine
The coupling of mono- and oligosaccharide units to the outer shell of dendritic or hyperbranched
architectures has been successful and the resulting amphiphilic macromolecules have been explored
as carrier systems for drugs [30–32] and DNA [33,34]. These systems, in addition to the increase in
biocompatibility, can utilize the molecular recognition potential of mono- and oligosaccharide units for
enhanced and selective cell uptake [35–40]. PPI dendrimers with a densely organized oligosaccharide
shell was proved to be a promising anti-prion agent and extensive studies on oligosaccharide shell
coupling to PEI based hyperbranched polymers has been reported [41]. Previously it has been
documented that the Cu2+ complexes of the polypeptide-shelled PPI dendrimers possess nearly the
same stability constants as the Cu2+ complexes of the unmodified PPI ones [42]. The study suggested
that the polypeptide chains do not alter the Cu2+ complexation ability of the dendritic PPI skeleton
significantly. Thus, it can be assumed that the dendritic PPI skeleton is the driving force for the
complexation of Cu2+ and it is independent of the attached peripheral chains as surface groups. In our
study, it is therefore presumed that attachment of oligosaccharide shells onto polyglycerolamine will
not adversely alter polyglycerolamine’s inherent Cu2+ complexation ability. To this end, maltose and
N-acetylglucosamine have been coupled to polyglycerolamine to utilize the purported recognition
potential of carbohydrate motif at glucose transferring receptor (GLUT) present in the BBB. Reductive
amination was adopted to immobilize the saccharide units as surface group. This reaction can result in
the simultaneous coupling of at least one (or two) saccharide units for one amino surface group with
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minimized synthetic effort [43]. This synthetic approach has also been described by several authors in
immobilizing oligosaccharide onto poly(lysine) and poly- (ornithine) monodendrons and dendrimers,
PPI dendrimers [42] and PEI [44] based hyperbranched system. In our case, polyglycerolamine (13,
fully functionalized, i.e., all hydroxyl groups of PG have been converted to primary amines) was
synthesized by previously published procedure from PG by subsequent steps of mesylation, azidation
and Staudinger reduction. The reductive amination of the polyglycerolamine with a large excess of
maltose or N-acetylglucosamine was carried out with a borane-pyridine complex as a strong reducing
agent in a sodium borate buffer, yielding N-acetyl-glucosamine linked polyglycerolamine (PG10-GLNC,
14) and maltose-modified polyglycerolamine (PG10-Mlt, 15). The 1H-NMR spectrum of 14 showed
signals in two characteristic regions: from 2.5 to 4.4 ppm (PG protons overlapped with those from
sugar) and from 5.0 to 5.3 ppm (anomeric proton from maltose). On the other hand, 1H-NMR spectrum
of 15 displayed a broad signal in the range of 1.9–2.2 ppm (CH3 group of the N-acetylgluocosamine)
followed by highly overlapping signals broadened from 2.5 to 4.5 ppm (proton from PG backbone
overlapping with those from sugar units). The reductive amination reaction of the reducing unit of the
parent (oligo-) saccharide yields a noncyclic unit partly restricted in mobility by its neighborhood to
the PG scaffold and, therefore, generating signals with different extents of broadening. Additional
broadening and splitting should be caused by different stereochemistry and by the substitution pattern
of the neighboring amine nitrogen. Nevertheless, for compound 15, signal at 22 ppm and for 14, at
100 ppm in 13C spectra after dialysis indicated the immobilization of the saccharide residue onto the
PG scaffold. It was difficult to conclude whether one or two units of sugar residues have been added
per amino group, however from 1H-NMR, the degree of functionalization was calculated which was
typically within the range of 48% for 14 and 54% for 15.
2.5. Attaching N-α-BOC-Histidine to Polyglycerolamine: BBB Targeted Nanocarriers
Brain microvascular endothelial cells (BMEC) are the major structural and functional components
of the BBB that maintain the homeostasis of the central nervous system. The plasma membrane of
BMEC has been shown to be the site of several carrier-mediated transport systems including those for
glucose, monocarboxylic acids and amino acids [45,46]. Xiang et al., provided evidence for there being
at least two pathways for L-histidine uptake into isolated choroids plexus, an Na+-independent and
an Na+-dependent process. Hikichi et al., studied the stereoselective BBB transport of histidine using
rat brain BMEC and reported the process to be saturable [47]. Their results suggested that L-histidine
is actively taken up by a carrier-mediated mechanism into the BMEC with energy supplied by Na+.
Considering these earlier data, we have immobilized a histidine analogue, N-α-BOC-Histidine was
immobilized onto polyglycerolamine (50% amino functionalized) to yield compound 16 (PG10-His)
in an attempt to utilize the Cu complexing capability of both polyglycerolamine and imidazole ring
system of the histidine moiety while exploiting the affinity of histidine nucleus towards System-L and
System-N transporters in the BBB. In this system, N-α-BOC-Histidine serves as the targeting modality
to target histidine transport receptors. The reaction chemistry is presented in Scheme 4.
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N-α-BOC-histidine was coupled to polyglycerolamine by using EDCI as the coupling agent in
the presence of catalytic amount of DMAP in DMF-water (1:1) mixture. An overnight dialysis in
methanol yielded pure compounds in 78% yield. 1H-NMR conclusively proves the immobilization of
the derivatives onto PG scaffold where the nine protons from BOC signals resonate at 1.09 ppm while
two protons from the imidazole rings of histidine nucleus appear at 6.52 and 7.84 ppm. The degree of
functionalization was adjusted to 20%, which resulted in water-soluble product.
2.6. Synthesis of FITC-Labelled PG10-TMEDA System
Compound 3f (approximately 70% level of functionalization) was tagged with FITC in the
presence of dibutyl tindilaurate as catalyst. Extensive dialysis in MeOH yielded the desired FITC
labeled 3f (FITC-PG10-TMEDA) for cellular uptake studies. UV-Vis spectrophotometric methods and
1H-NMR were used to characterize the labeled product.
2.7. Cu-Encapsulation by Synthesized hPG-Derived Nanocarriers: UV-Visible Spectroscopic Investigation
The primary objective of designing these synthetic constructs was to use them for complexing
and delivering Cu ion across cell membranes. To this end, the hPG-based architectures were first
tested for their Cu-complexing ability. UV/Vis spectroscopy is a method that is extensively used to
investigate qualitative as well as quantitative changes in the coordination sphere of transition-metal
complexes [48–51]. In the case of dendrimers, it was shown that dendritic structures can only
encapsulate a maximum number of metal ions per molecule [52]. The maximum metal loading
of the dendrimer and the value of the [metal ions]/[dendrimer] ratio determines the size of the formed
nanoparticles [53]. In our case, a similar approach to investigate the metal loading capacity by PG
based Cu encapsulating nanostructures was undertaken. Cu2+ encapsulated systems were prepared
by mixing equal volume of aqueous CuSO4 solution with respective polymer solution. An incubation
time for metal uptake was standardized to be 24 h. The encapsulated Cu2+ ion was not reduced
after complexation to form true nanoparticles since the therapeutic efficacy needs the Cu2+ ion to
be delivered in ionic form. The evidence for Cu2+ encapsulation by the respective PG based Cu2+
encapsulating constructs resides in the fact that, in pure aqueous solution copper sulfate forms a light
blue (aqua) copper complex, [Cu (H2O)6]2+, which has a wide absorbance maximum at 810 nm region.
On the formation of a complex between the amine moieties of polymer scaffold, this absorbance
maximum will be shifted to shorter wavelength. At this wavelength, a continuous variation plot of Cu
to polymer ratio will provide the maximum number of Cu ions that can be encapsulated per mole of
nanocarrier [54,55]. As a general procedure, to assess maximum metal-cargo capacity of dendrimers
and hyperbranched polymers, an aqueous solution of the individual nanotransporter (at various
concentrations calculated according to the Mn value) was mixed with an aqueous solution of Cu2+ to
obtain a distinct molar [Cu2+ ions/nanotransporter] ratio within the range of 0–100. As a representative
example, Figure 2a illustrates the complexation of copper ions with PG10-TMEDA1.0 system. A more
detailed biophysical and biochemical evaluation of Cu-complexing capacity of this candidate and
related molecular species has been communicated in our earlier publications [12–14]. In the absence
of a polymer with complexation capabilities, Cu2+ exists primarily as [Cu (H2O) 6]2+ in aqueous
solutions, which gave rise to a broad, weak absorption band at 810 nm associated with a d-d transition
(ε ~10). In the presence of 3f, λmax for the Cu2+ d-d transition was shifted to 735 nm. In addition,
a strong ligand-to-metal-charge-transfer (LMCT) transition appeared at 280–300 nm regions (Figure 2a).
With higher ratio of Cu2+ to polymer, the spectrum shows a tendency to shift towards the longer
wavelength. This change in UV-Vis spectrum allows following the Cu2+ ion binding with different
hyperbranched polymer systems bearing nitrogen atoms. In this experiment, the absorbance at λmax
at 735 nm increased with increasing [Cu2+]/[nanotransporter] ratio until a critical value is reached,
above which the absorbance increased only slowly. The shift in the absorption maximum at 735 nm
is mainly due to the complexed Cu ion co-ordinated within the four nitrogen system of TMEDA
structure across the polymeric scaffold. Figure 2b represents the general architecture of such TMEDA
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complexes with Cu2+, where the metal ion is bound between the four nitrogen atoms of TMEDA moiety
of compound 3f. A different UV-Vis absorbance pattern was observed when compound PG10-Mlt
14 or PG10-GLNC 15 was titrated with Cu2+. Figure 2c,d shows the absorption spectra of 14 in the
presence of increasing amount of Cu2+. The nanocarriers themselves do not absorb light significantly
above 250 nm. In the presence of Cu2+, a new peak at appears at 273 nm (Figure 2c for PG10-Mlt
system). This can be attributed to the ligand-to-metal charge-transfer (LMCT) transition of the Cu2+
encapsulated complexes [54,55]. This LMCT band were obtained when increasing amount of Cu2+ was
added to PG10-Mlt system in water.
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Figure 2. (a) Complexation of Cu2+ion by PG10-TMEDA1.0 system 3f as indicated by shift of absorbance
band at shorter wavelengths compared to that for free CuSO4 (b) Idealized structure of compound
3f, and the possible structurea of the complex (c) Complexation of Cu2+ ion by PG10-Mlt 14 can be
followed by gradual increase of absorbance at 273 nm. Cu/Polymer ratio of 10–70 is presented (d) Two
distinct region is present before and after maximum Cu loading by the PG10-Mlt 14 system which
diverges at [Cu]/[Polymer] = 50.
Comparative studies have been undertaken which revealed no interaction between maltose with
Cu2+. Therefore it can be assumed that the amino groups within the polymeric scaffold are responsible
for complexing Cu2+. Because of the low absorbance of d-d transitions (less than 0.12) at about 700 nm,
which is also associated with high signal-to-noise ratio, the LMCT transition at 290 nm was used for
quantitative evaluation of Cu2+/polymer complex. Figure 2d shows the absorbances of PG10-Maltose
system as a function of Cu2+ concentration. At low Cu2+ concentration, a linear increase in absorbance
at 274 nm was observed. In this region, an effective complexation takes place between Cu2+ ions and
hPGs. This gradual increase of absorbance eventually diminishes into an approximately linear region.
Here practically no complexation between Cu2+ and polymers takes place. The intersection point of
these two regions can be estimated as the maximum molar capacity of these carbohydrate modified
polyglycerolamine systems to load Cu2+ ions.
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For PG10-His system 16, a shoulder band at 290 nm, which gradually increases with increasing
Cu2+ concentration, was assigned as LMCT transition signals and similar procedures as mentioned
above was followed to determine the Cu2+-loading capacity of these nanocarriers. The high
signal-to-noise ratio of Cu2+/carrier complexes from 650 to 700 nm, associated with the problem
of overlapping of the LMCT region by the structural features of the carriers themselves restricted the
UV-Vis spectroscopic application to determine maximum metal-encapsulating capacity of PG10-NF135
11 and PG10-KR 455 12 systems. For these carriers, isothermal titration calorimetry (ITC) was used as
a method of choice to investigate their encapsulation/complexation behaviour.
2.8. Thermodynamics of Cu-Ion Encapsulation by hPG Nanoconstructs: Isothermal Titration Calorimetry (ITC)
Isothermal titration calorimetry (ITC) has proven its efficiency for studying thermodynamic
and kinetic properties of macromolecular interactions due to its ease of application and high level
of accuracy. ITC technique was used to follow the enthalpic interactions between hPG-derived
nanotransporter and Cu2+ ions, which in turn reflect the strength and extent of metal encapsulation
properties of the selected species. The energetics of encapsulation is critically important for designing
Cu-ion delivery systems as it governs the stability of the complex in fluctuating in vivo environment
before it reaches the target tissue. Encapsulation of all nanotransporters was analysed by measuring the
heat change during the titration of Cu2+ to nanotransporter solutions. The heat released or absorbed
during the titration process is in direct proportion to the amount of binding between the macromolecule
and the metal ion. In this experiment, isothermal titration calorimetry was performed in both orders,
i.e., nanotransporters added to Cu2+ ion solution and vice-versa to investigate the encapsulation event
quantitatively. It was found that, adding Cu2+ ion solution from the syringe to the nanotransporter
solution in the cell gives a better representation of the saturation process of the polymers by Cu2+
ions. A series of concentration experiments has been done for each of the nanotransporters to fix the
experiment parameters including the concentration of the hPG derivatives and the metal ion.
Figure 3 illustrates the isothermal titration calorimetric trace for PG-cNH2 architecture 8.
Encapsulation stoichiometry of Cu2+ ions by these nanocarriers was found to be a function of the
molecular weight of the PG core. Resulting binding isotherm representing the interaction of Cu2+ ions
to this nanotransporter was hyperbolic in nature with an initial rapid release of heat in the negative
side of titration baseline indicating exothermic interaction between Cu2+ ions and the nanocarriers.
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The enthalpic values, as illustrated in the figure, finally reached a plateau, which indicated
the end-point of titration confirming that all or at least most of the accessible binding sites of the
macromolecules have been saturated with the ligand. The negative value of apparent change in
enthalpy (∆Happ) indicated the predominant effect of charge-interaction in binding event. Different
statistical and qualitative approaches were undertaken to analyse the binding isotherm resulting from
calorimetric titration. In principle, the difference between the amount of energy liberated/absorbed at
the onset of titration and that at the end of the saturation process, generally gives the first approximation
of binding energy of interaction. Stoichiometry of binding can be calculated from the inflection point
of the titration curve. The stoichiometry can also be evaluated from the intersection points of different
kinetic regions within the binding isotherm before the saturation/plateau level of interaction is
reached. From exothermic heat release profile, it can be concluded that both core-functionalized
polyglycerolamines PG-cNH2 8 was complexing Cu2+ ions. PG10-cNH2 architecture was able to
complex 26 mole of Cu ion per mol of polymer, whereas PG5-cNH2 was encapsulating only 10 mole
of metal ion per mole of the nanocarrier. The heat of complex stabilization was almost of similar
order for both variants, which is within the range of −6.5 to −7 kcal mol−1 indicating considerably
stable complexes between Cu2+ ions and the polymers. The binding isotherms of these two polymeric
systems however showed that PG5-cNH2 is saturated with Cu2+ ions at a faster rate than that of its high
molecular weight counterpart. The observation might be due to easier accessibility of the metal ions
towards the linear amino groups for low molecular weight core. The change of complexation enthalpy
as a function of [Cu2+] to [nanocarrier] ratio followed a similar pattern for other nanocarrier systems.
The exothermic isotherms can be mainly attributed to the charge transfer based complexation between
the amine groups of the molecule and Cu2+ ions. Of the two carbohydrate-coupled polyglycerolamines,
PG10-Mlt 14 showed different energetic behavior on its interaction with Cu2+. At the onset of titration,
endothermic signals were generated which were gradually converted to exothermic heat flow (data
not shown). The observed facts could be due to two separate energetic processes occurring during
complexation. Similar effect was also reported previously where introducing larger oligosaccharide
units onto the host polymer changes the binding mechanism of guest molecule [56].
PG10-NF 135, 11 and PG10-KR 455, 12 systems were analyzed micro-calorimetrically in the same
manner to evaluate their Cu-complexing ability. Figure 4 shows the binding isotherms of these systems
with Cu2+ ions. As observed from Figure 4a, approximately 13 kcal/mol of energy has been liberated
on interaction of Cu2+ with PG10-NF 135 system, which indicates the formation of considerably strong
complex. On the other hand, Cu2+-PG10-KR 455 complex stabilization energy was only within the
range of 5 kcal/mol (Figure 4b). Intersection of the linear regions of binding isotherms affords the
maximum Cu2+-loading efficiency of the nanocarriers. The figure also shows that PG10-NF 135 (11)
can encapsulate ~45 mol of Cu/mol of carrier, while PG10-KR 455 (12) was able to bind ~55 mol of
Cu/mol of carrier.
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Depending on the variation of molecular architecture, Cu2+ saturation level and complex
stabilization energy varied with individual Cu2+ encapsulating systems. The binding isotherms of the
different nanocarriers with Cu2+ ion allowed the determination of maximum [Cu2+]/[nanocarrier]
ratio using the inflection method as per earlier published procedure [56]. Saturation stoichiometry
of the nanotransporters towards Cu2+ generated by analysing the titration curves is presented in
Table 3. The Cu-complexing capacity of compound 3f (i.e., PG10-TMEDA1.0, fully functionalized)
has been published in an earlier report [13]. Here we show that, compound 3f, functionalized with
TMEDA moiety at 50% and 10% functionalization level, also showed similar trend of Cu-encapsulation
characteristics as per ITC and UV-Vis measurements.
Table 3. Cu2+ complexing stoichiometry as determined by ITC and UV-Vis spectroscopy.
Compound No. Nanocarriers Mole of Cu2+/mol of Nanotransporter
ITC UV-Vis
3f (50%) * PG10-TMEDA0.5 31 36
3f (10%) * PG10-TMEDA0.1 14 15
8a PG10-cNH2 26 31
8b PG5-cNH2 10 17
11 PG10-NF 135 45 40
12 PG10-KR 455 55 48
14 PG10-Mlt N/D 40
15 PG10-GLNC N/D 42
16 PG10-His 35 N/D
N/D: not determined; It was not possible to accurately determine the saturation stoichiometry of Cu2+ by PG10-Mlt
or PG10-GLNC system by ITC (inadequate model fitting), and PG10-His by UV-Vis spectroscopic techniques (very
week LMCT signal). * % value inside parenthesis indicates the degree of functionalization of total number of
hydroxyl groups/mol of hPG.
2.9. Surface Charge Characteristics of Cu-Loaded hPG Nanocarriers
The surface charge, or zeta potential of nanocarriers governs a wide array of their biological
activity, including cellular permeability, biocompatibility, systemic stability, enzyme interaction,
metabolic degradation and toxicity. Hence, we have investigated the surface charge of the synthesized
Cu-nanocarriers either alone or in Cu-encapsulated form. Zeta potentials of the PG10-TMEDA
nanocarrier solution in PBS of pH 7.4 were measured for different degree of functionalization of
the construct. To assess the effect of Cu2+ on surface charge of PG10-TMEDA systems, the nanocarriers
were loaded with maximum stoichiometric amount of Cu (estimated from ITC and UV-Vis titration).
For optimal loading of Cu, after incubation, free metal ion was removed from the polymer-encapsulated
species by dialysis until a stabilized value of absorbance at 735 nm is obtained for the retentate
solution. The freeze-dried, PBS resuspended solution of nanocarriers was subjected to zeta potential
measurement. In case of PG10-TMEDA systems protonation may occur at all nitrogen atoms and
like amine terminated PAMAM dendrimers, the surface of the polyglycerolamines will be positively
charged and zeta potentials will gradually increase with increased percentage of cationic groups.
Typical results from the zeta potential measurements are illustrated in Figure 5a for PG10-TMEDA
system 3f in buffered aqueous solution. It is clearly observed that at pH 7.4, these systems were
positively charged and surface charge increases with increasing degree of functionalization of PG
scaffold with TMEDA moiety from +10.4 mV to as high as +18.2 mV. Loading PG10-TMEDA systems
with saturating concentration of Cu load (as measured from ITC/UV calculations) decreases the zeta
potential of the Cu-encapsulated complex. For example, PG10-TMEDA1.0 3f system exhibits surface
charge of +18.2 mV, which is decreased to 12.1 mV upon encapsulation of Cu2+ (Figure 5a). This charge
neutralization of the carrier system by Cu2+ proves the location of the metal ion adjacent to TMEDA
shell systems of the carrier molecule with probable involvement of the charge transfer mechanism.
The higher the degree of functionalization, the stronger is the charge neutralization, most likely due
to higher stoichiometric load of Cu ion within the polymer scaffold. Also considering the fact that,
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CuSO4 does not have any surface charge, the colloidal electrostatic charges of the resulting solution
over entire [Cu2+]/[PG10-TMEDA] functionalization range is essentially being contributed from the
Cu-encapsulated PG10-TMEDA system. Surface charge properties of PG-cNH2 8 system were found
to be a function of molecular weight of the PG core. PG10-cNH2 derived from 10 kDa PG scaffold
exhibit higher zeta potential (16.4 mV) than PG5-cNH2 species with 5 kDa PG core (10.4 mV). For
carbohydrate-modified carriers, surface charge was substantially low.
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Table 4 summarizes the zeta potential values of the studied nanocarriers:
Table 4. Zeta potential of PG based Cu-encapsulating systems.
Compound No. Nanocarriers Zeta Potential (mV)
11 PG10-NF 135 (+) 36.0 ± 1.0
12 PG10-KR 455 (+) 38.5 ± 0.5
3a PG10-DMA (+) 28.0 0.5
14 PG10-Mlt (−) 1.5 ± 1.0
15 PG10-GLNC (+) 5.0 ± 0.5
16 PG10-His (+) 8.5 ± 1.0
2.10. Interaction of Cu-Ion Encapsulating Systems with Plasma Albumin
The effectiveness of drug or delivery system candidates depends heavily on their interaction
with naturally occurring plasma proteins within the systemic circulation. This is particularly critical
when the polymeric architectures possess high surface charge, molecular weight, and have tendency
to interact with biomacromolecules in blood due to their surface properties. In general, the extent
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of interactions between bioactive molecules and serum is quantified by Stern-Volmer constants,
reflecting tryptophan fluorescence quenching efficiency of the ligands, where the amino acid being
the integral part of BSA construct. Furthermore, these interactions are measured in terms of binding
constants or binding associations. Reported studies have been directed to realize the interactions of
polyamidoamine (PAMAM) dendrimers (fatty acid free and loaded with fatty acids) with serum
albumins (SA), for their physiological significance in developing nano-carrier systemic delivery
system [57]. In our case, fluorescence spectroscopic studies were carried out in phosphate buffered
saline solution. Emission spectra were recorded from 300 to 440 nm after excitation at 295 nm.
In buffered aqueous solution, BSA exhibits a characteristic emission spectrum of the tryptophan
fluorophore, with a distinct peak maximum at around 340 nm. In order to investigate the interaction
between dendritic polyglycerols and BSA, changes in the intensity of the emission spectra of BSA upon
addition of hPG-constructs were monitored. As can be seen from the spectra in Figure 5b, addition
of PG10-TMEDA0.5 3f–b to BSA in buffer led to a significant decrease in the intensity. When the
PG10-TMEDA0.1 3f–c carrier was added to the solution of BSA, the spectra showed only a slight
decrease in the fluorescence intensity; therefore suggesting much weaker binding interactions to BSA
indicating the interaction is operating mainly through the TMEDA groups coupled to PG. On the
contrary, in the experiment with PG10-Mlt, emission spectra of BSA were less affected by the presence of
the attached maltose units onto PG scaffold (data not shown). The distinct decrease in the fluorescence
intensity, as in Figure 5b, upon addition of polymers can be utilized in studying the interaction of PG
based carriers with BSA quantitatively by using classical Stern–Volmer equation [58–60]:
F0/F = 1+ kq × τ0 × [Q] = 1+ KSV × [Q] (1)
where F0 and F are, respectively, BSA fluorescence intensities in the absence and presence of polymer,
KSV is the Stern–Volmer quenching constant, [Q] is the concentration of polymer, kq is the bimolecular
quenching constant, and τ0 is the lifetime of the fluorophore in the absence of quencher. If diffusion
controlled, collisional quenching process is assumed, Equation (1) can be applied to properly fit the
experimental data.
The slope of Stern-Volmer equation equals to KSV and usually reveals the accessibility of the
polymers to the albumin fluorophore, hence the interaction and potential protein binding capacity of
the quencher [59]. More precisely, a linear plot is generally indicative of a single class of fluorophores,
all equally accessible to the quencher molecules. Typical results of Stern-Volmer constants of other
carriers are presented in Figure 5c. Spectroscopic results imply that the electrostatic interaction is the
main driving force for binding of these nanocarriers to negatively charged BSA. For example, if the
PG10-TMEDA 3f systems (light blue colour bars) are considered, it is clearly apparent that the extent of
interaction which is quantified by Stern-Volmer constant, decreases with decreasing functionalization
level of PG hydroxyl groups by TMEDA moiety. Similar trend can be observed with PG-cNH2 system,
where the KSV value clearly depends on molecular weight of the PG core. Attachment of sugar residue
onto PG scaffold essentially reduces the interaction with BSA. On the contrary, PG10-NF 135 11 and
PG10-KR 455 12 system exhibited substantially high interaction with BSA probably due to the presence
of heterocyclic ring, which facilitates non-specific attachment with BSA in addition to hydrophobic
mediated interactions.
2.11. Cellular Toxicity and Uptake of Representative hPG-Derived Nanocarriers
Cellular toxicity studies of the architectures in human hematopoietic cell line U-937 are shown
in Figure 6. A set of four parameters were considered for the evaluation of the Cu2+ nanocarrier
systems: (a) Cell number; (b) MTT-test for metabolic activity (c) Cell viability and (d) Apoptosis in
terms of cell diameter with respect to dexamethasone control. In all the cases, PG10-His 16, PG10-Mlt
14 and PG10-GLNC 15 showed substantial cell viability, unaltered cell diameter, normal metabolic
activity and significant cellular biocompatibility than PG10-DMA 3a, PG10-NF135 11 and KR455 12,
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and architectures. Figure 6 illustrates the representative cell-toxicity study obtained with PG10-GLNC
system 15. In addition to control, we have added dexamethasone to evaluate the effect of a known
cytotoxic agent within the same concentration as that for our test samples. As evident from the figure,
the number of viable cells, metabolic status and cell viability in general were virtually unaffected by
PG10-GLNC (15) or by PG10-His systems (compound 16). This might be due tohe biocompatibility of
N-acetylglucosamine or histidine analogue that has been attached onto polyglycerolamine scaffold.
On the other hand, PG10-KR 455 12 system was found to be highly toxic to the U-937 cell line as
illustrated in supporting information, and so was dimethylamine-substituted hPG (compound 3a).
Cytotoxicity data of compound 3f has been published in our earlier report [13]. This observation might
be attributed to extremely strong Cu-binding efficiency of these systems, which possibly depleted
essential metal ions from cellular microenvironment. We have also studied a short-term incubation
of PG10-TMEDA 3f system with 90% level of functionalization and PG10-cNH2 with living neuronal
SY5Y cell lines. When the cell lines were subjected to Cu loaded and FITC-labelled PG10-TMEDA
system, green fluorescence of FITC was observed around the DAPI stained nucleus on superimposing
image, confirming the cellular uptake of the carrier system within the cytoplasm (Figure 6d) starts
taking place within 30 min as observed in confocal microscopy based experiments. We have also
reported a more extensive cellular and biochemical property of this system, which showed that, not
only PG10-TMEDA systems were capable of internalization inside cytosol, they were also able to
engage with cytoplasmic metal processing machinery [13,14]. In a similar way, core-functionalized
polyglycerolamine, PG10-cNH2 8a tagged with FITC was investigated for cellular uptake in SH-SY5Y
cell-line, and the dye-labelled nanoparticles were found to be associated to the nuclear membrane
after 30 min of incubation period (data not shown). Since these cationic constructs do not contain
any receptor-specific ligand, the observed cellular uptake of is most likely triggered by non-specific
endocytosis, followed by endosomal escape through proton-sponge effect.
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Figure 6. Cellular studies with U-937 cell-line treated with different hPG derivative Clock-wise: (a) Cell
number (b) metabolic activity; and (c) Cell viability (d) Presence of FITC-labelled compound 3f in
cytosol after 30 min incubation with SY5Y cell lines.
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3. Discussion
We found that, bare hPGs do not encapsulate Cu ion to a significant extent. Modification of PG
core is required to introduce Cu-encapsulating modalities within the molecule. This has been achieved
either by activating the PG hydroxyl group to an efficient leaving group, following nucleophilic
substitution with different dialkylamine moieties or, by step-wise conversion of PG hydroxyl groups
to primary amines. Cu-encapsulating moiety can be strategically localized either within the core,
or introduced statistically throughout the molecule. The complex formation of hPG-derivatives
with the metal is believed to take place through the displacement of water molecules surrounding
Cu2+ ion in aqueous solution. Along with typical mechanism of charge transfer from N-atom of the
polymer towards Cu2+ ion, it is also assumable that there is an enthalpic-entropic compensation in the
formation of such complexes. The role of entropic part in addition to enthalpic component in host-guest
interaction [61–63] is a well-documented phenomena particularly in case of charge-interactions [64].
Encapsulation of a guest species, Cu in this case, resulted in reduced rotation of bonds and higher
ordered structures applicable to all tested candidates. The partial/total loss of hydrate shell around Cu
ion set water molecules free which increased entropy and might compensate for the loss of rotational
freedom after encapsulation [65]. We have reported earlier, that compound 3f, at full functionalization
level, not only showed high affinity encapsulation of Cu2+, but also a pH-dependent release in aqueous
environment [13]. The stability of all tested complexes at pH 7.4 is important to retain the integrity of
the complex in the blood stream before accumulation into target tissues. On the other hand, gradual
release of Cu in acidic environment will be of critical importance in the liberation of Cu ion within the
cytosol after endocytosis.
hPG-derivatives with primary amine groups at the core (compounds 8a and 8b), showed
Cu-encapsulation efficiency as a function of the MW of the core. Heat of complex stabilization
was almost similar for both molecular weight variants, however, the rate of saturation of nanocarriers
were much faster in case of high MW PG-species 8 than their low MW counterparts (Figure 3). This
can be attributed to the higher accessibility Cu towards the linear amino groups in case of low
MW polyglycerolamine. Similarly, hPG-derived compounds, particularly those conjugated with
bioactive ligands such as maltose, N-acetylglucosamine and histidine showed increased toxicity
tolerance for free Cu (Figure 6) in the cell. Attaching carbohydrate functionalities to the core, i.e.,
maltose and N-acetylglucosamine, as in compounds 14 and 15 respectively, is a well-documented
approach to increase compartmentalization of guest molecules and to exert biocompatibility. In this
project, addition of carbohydrate fragments was envisioned to stabilize the Cu2+ complex formed
within the polyglycerolamine scaffold. These architectures were found to be the most non-toxic of all
the synthesized architectures in U-937 cell-line in terms of cell-viability, metabolism and apoptosis.
Improvement of biocompatibility scenario through incorporation of carbohydrate shell has been
reported before [56]. Attachment of bispicolylamide derivatives to PG improved the Cu2+ binding
ability of PG based nanocarriers to a considerable extent (Figure 4). PG10-NF135 11 was found to
be the strongest Cu2+ complexing nano-architectures among the synthesized candidates in terms of
binding energy. Compound 11 was found to accommodate ~55 moles of Cu/mol of polymer with
an energy range of 13 kcal mol−1. Unfortunately, the bispicolylamide derivative immobilized PG
nanocarriers exhibited substantial level of toxicity compared to control. This could be attributed
to strong chelating ability of bispicolylamide towards Cu, and also to other metals that might have
damaged normal metal homeostasis within cellular environment. Similar results were also reflected
in binding experiments of nanocarriers with serum albumin. Stern-Volmer constant (KSV), which is
considered as a quantitative extent of interaction with BSA with a given quencher molecule, decreased
gradually in the following order: PG10-DMA, 3a > PG10-NF135, 11, PG10-KR 455, 12 > PG10-TMEDA1.0,
3f > PG10-His, 16, PG10-TMEDA0.5 3f-b > PG10-Mlt, 14, and PG10-GLNC, 15. When neuronal cells,
such as SY5Y, were treated with FITC-tagged 3f derivatives, FITC fluorescence from the nanocarriers
were visualized near the DAPI stained nucleus indicating that the systems were uptaken by the
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cells through non-specific endocytosis followed by endosomal escape. In case of core-functionalized
polyglycerolamine, accumulation of the nanocarriers on or near nuclear membrane was evident.
The experimental significance of this work principally indicates that, it is possible to construct
multivalent hPG-based ligand for spontaneous encapsulation of Cu ion to generate biocompatible
Cu-complexing macromolecular constructs. The strength and complexation property can be optimized
by selective functionalization of the hydroxyl groups of hPG scaffold by different structural modalities,
which in turn also governs cellular uptake and toxicity of the nanocarriers. The optimized hPG-derived
architectures can find potential application in addressing disease and nutritional deficiency conditions
where exogenous administration of Cu is required.
4. Experimental Section
4.1. Materials
PG (Mn = 10,000 g/mol) synthesized from TMP starter, MWD = 1.7) was prepared by the Haag
group according to a previously published procedure. All PG samples were concentrated and dried
under vacuum (50 ◦C, 1 × 10−2 mbar) until loss of weight was lower than 0.025 g per 1.0 g of the
dried sample in 5 h drying periods. This process was accepted as a standard procedure followed
also in previous works. Commercially available chemicals from standardized sources have been
used and used as delivered. Solvents were purchased as reagent grade and distilled if necessary.
Anhydrous solvents were either purchased as ultra dry solvent from Acros Organics® (Fisher Scientific,
Im Heiligen Feld, Schwerte, Germany) or received from solvent purification system. The following
spectrometers were used for recording 1H-NMR and 13C-NMR spectra: DRX 500 and AMX 500
spectrometers, (Bruker, Billerica, MA, USA). Typically, 10–30 mg of compound was used for recording
1H-NMR while 50–100 mg of compounds were required for 13C-NMR. Deuterated solvents were used
as standardized procedure. All spectra were recorded at r.t. and were analyzed with Win NMR®
software (Bruker, Billerica, MA, USA). Benzoylated cellulose membrane purchased from Sigma-Aldrich
(Munich, Germany), MWCO = 1000 was used to perform dialysis. Typically, dialysis was carried out for
24 h with 1 L of solvent that was exchanged after first 6 h of the process. Size exclusion chromatography
(SEC) was performed with Sephadex LH 20 or Sephadex G 25 from GE Healthcare (Little Chalfont, UK).
The material was activated by swelling in the respective eluent prior to performing chromatography.
In case of using CHCl3, the beads were activated in the presence of 10% ethanol. TLC was performed
on aluminium sheets with silica (corn size 60) and fluorescence marker (F254) (Merck, Darmstadt,
Germany). Flash column chromatography was performed on Merck silica (corn size 60).
4.2. UV-Vis Spectroscopy
UV/Vis spectra were recorded with a S-3150 instrument (Scinco, Seuol, Korea) range: 190–1100 nm,
resolution 1024 points) in fast mode. Calibration was performed at 360.85 and 453.55 nm with holmium
oxide glass. The spectra were recorded at r.t. and were evaluated with Labpro® Plus from Scinco
Co., Ltd., Microsoft® Excel 2000 (Microsoft Inc., USA), and Origin® 7.0 from Origin Lab Corporation
(Redwood City, MA, USA).
4.3. Isothermal Titration Calorimetry (ITC)
A Microcal VP-ITC microcalorimeter (MicroCal, LLC, Northampton, MA, USA) was used to carry
out the calorimetric experiments. Experimental parameters for titration experiments were: number of
injections 34, cell temperature 30 ◦C, stirring speed 290 rpm, cell volume 1.43 mL, injection volume
8 µL, injection duration 16 s, spacing 300 s and filter speed 2 s and reference power 10 µcal s−1.
4.4. Zeta Potential Measurement
Zeta potential measurement were carried out on a Zetasizer Nano ZS analyzer with integrated
4 mW He-Ne laser, λ = 633 nm (Malvern Instruments Ltd., Malvern, UK). Doppler anemometry
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technique was used whereby electric field was applied across the sample solution. All measurements
were carried out at 25 ◦C using folded capillary cells (DTS 1060). The medium was PBS (pH 7.4) and
particle concentration used was 2 mg/mL.
4.5. Fluorescence Spectroscopic Studies
Fluorescence emission spectra were taken with a FP—6500 spectrofluorometer (Jasco, Deutschland,
Pfungstadt, Germany) equipped with a thermostated cell holder, a DC-powered 150 W xenon lamp, a R
928 photomultiplier and a versatile slit system. For polymer-BSA interaction studies, emission spectra
were recorded in from 300 nm to 440 nm after excitation at 295 nm. Both excitation and emission slits
were set at 5 nm. The sample solutions used for fluorescence measurement were stirred thoroughly by
using a laboratory vortex shaker and incubated for at least half an hour at 25 ◦C before measuring the
fluorescence. All measurements were carried out at 25 ◦C.
4.6. Synthesis of Core-Functionalized Polyglycerolamine; Ketalization of PG: Protection of Terminal Diols 4
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the reaction period, ice was added to the reaction mixture on which a dark brown solid precipitated, 
which was, after decantation of the liquid phase, washed with H2O, dissolved and dialyzed in 
chloroform to give a brown honey-like product in 87% yield. Conversion: quant. 1H-NMR (500 MHz, 
Ketalization of PG has been done following the already published procedure [22]. To a mixture
of PG (10.0 g, 40.54 mmol of diol units, 1.0 eq.) and 0.4 mol (10.0 eq.) of acetone dimethyl acetal,
0.77 g (10 mol%) of PTSA was added. The reaction was allowed to run overnight under r.t. The crude
product was diluted in chloroform and then extracted three times with saturated Na2CO3 solution to
remove the remaining PTSA. The organic phase was dried over MgSO4. Dialysis in chloroform for
48 h was carried out to remove the traces of dimethylacetal and PTSA. The purified product was dried
under vacuum to yield the polyketal as viscous, yellowish, transparent oil in 93% yield. Conversion:
quant. (all hPG diols, 30% of total hydroxyl groups were converted). 1H-NMR (500 MHz, CDCl3):
δ (ppm) = 1.17 (s, CCH3, ketal), 1.20 (s, CCH3, ketal), 3.28–4.06 (PG-backbone); 13C-NMR: (CDCl3):
δ (ppm) = 26.1 (C-CH3, ketal), 27.6 (C-CH3, ketal), 64.2–80.1 (m, PG-backbone), 109 (C-CH3, ketal);
IR (KBr)
−
υ = 3440, 2980 (ketal; CH3), 2920, 2865, 1210 cm−1.
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4.6. Synthesis of Core-Functionalized Polyglycerolamine; Ketalization of PG: Protection of Terminal Diols 4 
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was cooled down to 0 °C by means of ice/NaCl bath and a solution of MsCl (3.0 mL, 4.5 g, 39.26 mmol, 
1.2 eq.) in abs. pyridine (20 mL) was added drop-wise so that the temperature did not exceed 5 °C. 
The brown mixture was stirred for 16 h in the thawing ice bath. In case of full functionalization, after 
the reaction period, ice was added to the reaction mixture on which a dark brown solid precipitated, 
which was, after decantation of the liquid phase, washed with H2O, dissolved and dialyzed in 
chloroform to give a brown honey-like product in 87% yield. Conversion: quant. 1H-NMR (500 MHz, 
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t t ( . , . l - r s, 1.0 eq.) in a thr e- ecked 250 mL flask equi ped with
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ixt re was sti re for 16 h in the thawing ice bath. In case of full fu ctionalization,
afte the reaction period, ice was added to the reaction mixture on which a dark b own soli
precipitated, which was, after decantation of the liquid phase, washed with H2O, dissolved and
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dialyzed in chloroform to give a brown honey-like product in 87% yield. Conversion: quant. 1H-NMR
(500 MHz, CDCl3): δ (ppm) = 1.19 (s, CCH3, ketal), 1.22 (s, CCH3, ketal), 3.13 (bs, -CH3), 3.28–4.26
(PG-backbone); 13C-NMR: (CDCl3): δ (ppm) = 27.1 (C-CH3, ketal), 29.6 (C-CH3, ketal), 35.3 (CH3),
64.2–82.1 (m, PG-backbone), 105 (C-CH3, ketal); IR (KBr)
−
υ = 3040, 2980 (ketal; CH3), 2932, 2918, 2869,
2350, 1709, 1450, 1201) cm−1.
4.8. Procedure for the Synthesis of Ketal Protected Polyglycerolazide 6
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4.8. Procedure for the Synthesis of Ketal Protected Polyglycerolazide 6 
 
In a 250 mL one-necked flask with reflux condenser and magnetic stirrer was dissolved ketal 
protected O-mesylpolyglycerol (6.0 g, 18.06 mmol OMs-group, 1.0 eq.) in p.a. DMF. After complete 
dissolution of the mesylated derivative, NaN3 (5.87 g, 90.32 mmol, 5.0 eq.) was added to the flask and 
the resulting suspension was heated at 60 °C for 3 days behind a transparent security wall. After 
cooling, filtration delivered a bright yellow filtrate and a white residue of excess NaN3. The filtrate 
was concentrated in vacuo at temperature below 40 °C and only handled with plastic spatula to avoid 
explosive degradation of polyazide. In case of complete functionalization, the residue was dissolved 
in CHCl3 and extracted four times with water. The organic phase was dried over MgSO4 and 
concentrated in vacuo. Further dialysis in CHCl3 was carried out for 24 h to remove traces of DMF 
from the crude product. Extensive dialysis in CHCl3 for 24–48 h was carried out to yield 
polyglycerolazide as brown-paste like compound. Yield: 75%; Conversion: quant. 1H-NMR (500 
MHz, CDCl3): δ (ppm) = 1.18 (s, CCH3, ketal), 1.20 (s, CCH3, ketal), 3.41–4.26 (PG-backbone); 13C-
NMR: (CDCl3): δ (ppm) = 25.1 (C-CH3, ketal), 26.6 (C-CH3, ketal), 65.5–80.1 (m, PG-backbone), 107 (C-
CH3, ketal); IR (KBr) ῡ = 2976 (ketal; CH3), 2870, 2350, 2101 (N3), 1465, 1234 cm−1. 
4.9. Deprotection of Ketal Protected Polyglycerol Azide 7 
 
To a solution of ketal protected polyglycerolazide (1.77 g) in 25 mL MeOH, 2.0 g of Dowex-500 
resin was added after activation. The mixture was stirred and heated at reflux for 18 h. The crude 
product was filtered, and the filtrate was concentrated, dried under vacuum and subjected to MeOH 
dialysis overnight. Yield: 70%; Conversion: quant. 1H-NMR (500 MHz, CDCl3): δ (ppm) = 1.81 (PG-
starter), 3.41–4.26 (PG-backbone); 13C-NMR: (CDCl3): 50.1 (functionalized primary PG-groups) 65.5–
80.1 (m, PG-backbone); IR (KBr) ῡ = 3300, 2802, 2365, 2101 (N3), 1234 cm−1. 
4.10. Synthesis of Core-Functionalized Polyglycerolamine 8 
 
Deprotected polyglycerolazide (1.89 g, 7.79 mmol N3 group, 1.0 eq.) was dissolved in p.a THF 
(40 mL) in 250 mL one-necked flask. H2O (10 mL) and PPh3 (2.04 g, 7.79 mmol, 1.0 eq.) were added 
and N2 formation was observed. Volume of water was increased gradually by dropwise addition of 
In a 250 L one-necked flask ith reflux condenser and agnetic stirrer as dissolved ketal
protected O- esylpolyglycerol (6.0 g, 18.06 ol O s-group, 1.0 eq.) in p.a. D F. After co plete
dissolution of the mesylated derivative, aN3 (5.87 g, 90.32 mmol, 5.0 eq.) was added to the
flask and the resulting suspension was heated at 60 ◦C for 3 days behind a transparent security
wall. After cooling, filtration delivered a bright yellow filtrate and a white residue of excess NaN3.
The filtrate was concentrated in vacuo at temperature below 40 ◦C and only handled with plastic
spatula to avoid explosive degradation of polyazide. In case of complete functionalization, the residue
was dissolved in CHCl3 and extracted four times with water. The organic phase was dried over
MgSO4 and concentrated in vacuo. Further dialysis in CHCl3 was carried out for 24 h to remove
traces of DMF from the crude product. Extensive dialysis in CHCl3 for 24–48 h was carried out to
yield polyglycerolazide as brown-paste like compound. Yield: 75%; Conversion: quant. 1H-NMR
(500 MHz, CDCl3): δ (ppm) = 1.18 (s, CCH3, ketal), 1.20 (s, CCH3, ketal), 3.41–4.26 (PG-backbone);
13C-NMR: (CDCl3): δ (ppm) = 25.1 (C-CH3, ketal), 26.6 (C-CH3, ketal), 65.5–80.1 (m, PG-backbone),
107 (C-CH3, ketal); IR (KBr)
−
υ = 2976 (ketal; CH3), 2870, 2350, 2101 (N3), 1465, 1234 cm−1.
4.9. Deprotection of Ketal Protected Polyglycerol Azide 7
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Deprotected p lygly erolazide (1.89 g, 7.79 mmol N3 group, 1.0 eq.) was dissolved in p.  THF 
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To a solution of ketal protected polyglycerolazide (1.77 g) in 25 mL MeOH, 2.0 g of Dowex-500
resin was added after activation. The mixture was stirred and heated at reflux for 18 h. The crude
product was filtered, and the filtrate was concentrated, dried under vacuum and subjected to MeOH
dialysis overnight. Yield: 70%; Conversion: quant. 1H-NMR (500 MHz, CDCl3): δ (ppm) = 1.81
(PG-starter), 3.41–4.26 (PG-backbone); 13C-NMR: (CDCl3): 50.1 (functionalized primary PG-groups)
65.5–80.1 (m, PG-backbone); IR (KBr)
−
υ = 3300, 2802, 2365, 2101 (N3), 1234 cm−1.
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from the crude product. Extensive dialysis in CHCl3 for 24–48 h was carried out to yield 
polyglycerolazide as brown-paste like compound. Yield: 75%; Conversion: quant. 1H-NMR (500 
MHz, CDCl3): δ (ppm) = 1.18 (s, CCH3, ketal), 1.20 (s, CCH3, ketal), 3.41–4.26 (PG-backbone); 13C-
NMR: (CDCl3): δ (ppm) = 25.1 (C-CH3, ketal), 26.6 (C-CH3, ketal), 65.5–80.1 (m, PG-backbone), 107 (C-
CH3, ketal); IR (KBr) ῡ = 2976 (ketal; CH3), 2870, 2350, 2101 (N3), 1465, 1234 cm−1. 
4.9. Deprotection of Ketal Protected Polyglycerol Azide 7 
 
To a solution of ketal protected polyglycerolazide (1.77 g) in 25 mL MeOH, 2.0 g of Dowex-500 
resin was added after activation. The mixture was stirred and heated at reflux for 18 h. The crude 
product was filtered, and the filtrate was concentrated, dried under vacuum and subjected to MeOH 
dialysis overnight. Yield: 70%; Conversion: quant. 1H-NMR (500 MHz, CDCl3): δ (ppm) = 1.81 (PG-
starter), 3.41–4.26 (PG-backbone); 13C-NMR: (CDCl3): 50.1 (functionalized primary PG-groups) 65.5–
80.1 (m, PG-backbone); IR (KBr) ῡ = 3300, 2802, 2365, 2101 (N3), 1234 cm−1. 
4.10. Synthesis of Core-Functionalized Polyglycerolamine 8 
 
Deprotected polyglycerolazide (1.89 g, 7.79 mmol N3 group, 1.0 eq.) was dissolved in p.a THF 
(40 mL) in 250 mL one-necked flask. H2O (10 mL) and PPh3 (2.04 g, 7.79 mmol, 1.0 eq.) were added 
and N2 formation was observed. Volume of water was increased gradually by dropwise addition of 
Deprotected polyglycerolazide (1.89 g, 7.79 ol 3 group, 1.0 eq.) as dissolved in p.a T F
(40 L) in 250 mL one-necked flask. H2O (10 mL) and PPh3 (2.04 g, 7.79 mmol, 1.0 eq.) were added and
N2 formation was observed. Volume of water was increased gradually by dropwise addition of water
(30 mL) through a drop funnel to avoid precipitation of the partially reduced product. The reaction was
continued until the azide signal at 2100 cm−1 is completely diminished. In most of the cases, depending
on the level of functionalization of PG core, the complete reduction of N3 to NH2 group required 5 to
7 days. After that, the mixture was concentrated to in vacuo to smaller volume, CHCl3 was added
and the phases were separated using a separation funnel. The aqueous layer was extracted with
CHCl3 four times and then concentrated to dryness to deliver a brown honey-like product, which was
dialyzed in MeOH. The purified product was not completely dried off MeOH, and stored under inert
gas to avoid potential cross-linking. Yield: 65%; Conversion: quant.; 1H-NMR (500 MHz, CD3OD):
δ (ppm) = 4.01–3.25 (PG), 2.86–2.73 (m, broad, NH2 functionalized-PG groups), 0.92 (PG-starter);
13C-NMR: (CD3OD): 58.3 (functionalized primary PG-groups) 67.5–76.1 (m, PG-backbone); IR (KBr)
−
υ = 3441, 2872, 1455, 1208, 1104 cm−1.
4.11. Core Functionalization of PG Acetal with N1,N1,N2-Trimethylethane-1,2-Diamine 9
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water (30 mL) through a drop funnel to avoid precipitation of the partially reduced product. The 
reaction was continued until the azide signal at 2100 cm−1 is completely diminished. In most of the 
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product, which was dialyzed in MeOH. The purified product was not completely dried off MeOH, 
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0.92 (PG-starter); 13C-NMR: (CD3OD): 58.3 (functionalized primary PG-groups) 67.5–76.1 (m, PG-
backbone); IR (KBr) ῡ = 3441, 2872, 1455, 1208, 1104 cm−1. 
4.11. Core Functionalization of PG Acetal with N1,N1,N2-Trimethylethane-1,2-Diamine 9 
 
In a sealed tube, mesylated PG acetal (1.0 g, 2.10 mmol OMs group, 1.0 eq.) was dissolved in 10 
ml of p.a. DMF. N1,N1,N2-trimethylethane-1,2-diamine (0.858 g, 8.40 mmol, 4.0 eq., 1.1 mL) was added 
slowly at RT and the resulting solution was heated at 120 °C for 4 days. At the end of the reaction, 
the tube was cooled to RT and DMF was removed by cryo-distillation. The residue was dissolved 
and dialyzed in MeOH for 48 h to give the dark brown honey-like product. Yield: 64%; Conversion: 
quant (all hPG diols, 30% of total hydroxyl groups were converted); 1H-NMR (500 MHz, CD3OD): δ 
(ppm) = 4.25–3.54 (PG-groups), 2.41–2.34 (d, broad, -N-(CH3)2), 1.41–1.35 (d, broad, -CH3); 13C-NMR: 
(CD3OD): δ (ppm) = 112.4 (C-CH3, ketal), 80.1–64.3 (PG-backbone), 48.6–43.3 (-N-CH3), 45.3–40.2 (-N-
(CH3)2), 28.2 (C-CH3, ketal), 25.4 (C-CH3, ketal); IR (KBr) ῡ = 3142, 2975 (ketal; CH3), 2892, 2865, 1680, 
1354, 1210 cm−1. 
4.12. Procedure for the Synthesis of PG-cNH2 Containing 6-((tert-butoxycarbonyl(pyridin-2-ylmethyl)-
amino)methyl)nicotinic Acid 11 
 
6-((tert-Butoxycarbonyl(pyridin-2-ylmethyl)amino)methyl)nicotinic acid (NF 135) (0.029 g, 0.087 
mmol, 1.0 eq.) was dissolved in 3 mL p.a. DMF in a one necked 10 mL round-bottomed flask. To the 
resulting solution, EDCI (0.018 g, 0.096 mmol, 1.1 eq.) and catalytic amount of DMAP (0.001 mmol, 1 
mol%) was added while stirring at 0 °C. After 15 min, a solution of PG-cNH2 (0.1 g, 0.43 mmol NH2 
group, 20% of which will be functionalized with nicotinic acid moiety) in 1 mL p.a. DMF was added 
drop-wise to the reaction mixture for 30 min. The reaction was allowed to run for 24 h and the 
In a sealed tube, mesylated PG acetal (1.0 g, 2.10 mmol OMs group, 1.0 eq.) was dissolved in
10 mL of p.a. DMF. N1,N1,N2-trimethylethane-1,2-diamine (0.858 g, 8.40 mmol, 4.0 eq., 1.1 mL) was
added slowly at RT and the resulting solution was heated at 120 ◦C for 4 days. At the end of the
reaction, the tube was cooled to RT and DMF was removed by cryo-distillation. The residue was
dissolved and dialyzed in MeOH for 48 h to give the dark brown honey-like product. Yield: 64%;
Conversion: quant (all hPG diols, 30% of total hydroxyl groups were converted); 1H-NMR (500 MHz,
CD3OD): δ (ppm) = 4.25–3.54 (PG-groups), 2.41–2.34 (d, broad, -N-(CH3)2), 1.41–1.35 (d, broad, -CH3);
13C-NMR: (CD3OD): δ (ppm) = 112.4 (C-CH3, ketal), 80.1–64.3 (PG-backbone), 48.6–43.3 (-N-CH3),
45.3–40.2 (-N-(CH3)2), 28.2 (C-CH3, ketal), 25.4 (C-CH3, ketal); IR (KBr)
−
υ = 3142, 2975 (ketal; CH3),
2892, 2865, 1680, 1354, 1210 cm−1.
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slowly at RT and the resulting solution was heated at 120 °C for 4 days. At the end of the reaction, 
the tube was cooled to RT and DMF was removed by cryo-distillation. The residue was dissolved 
and dialyzed in MeOH for 48 h to give the dark brown honey-like product. Yield: 64%; Conversion: 
quant (all hPG diols, 30% of total hydroxyl groups were converted); 1H-NMR (500 MHz, CD3OD): δ 
(ppm) = 4.25–3.54 (PG-groups), 2.41–2.34 (d, broad, -N-(CH3)2), 1.41–1.35 (d, broad, -CH3); 13C-NMR: 
(CD3OD): δ (ppm) = 112.4 (C-CH3, ketal), 80.1–64.3 (PG-backbone), 48.6–43.3 (-N-CH3), 45.3–40.2 (-N-
(CH3)2), 28.2 (C-CH3, ketal), 25.4 (C-CH3, ketal); IR (KBr) ῡ = 3142, 2975 (ketal; CH3), 2892, 2865, 1680, 
1354, 1210 cm−1. 
4.12. Procedure for the Synthesis of PG-cNH2 Containing 6-((tert-butoxycarbonyl(pyridin-2-ylmethyl)-
amino)methyl)nicotinic Acid 11 
 
6-((tert-Butoxycarbonyl(pyridin-2-ylmethyl)amino)methyl)nicotinic acid (NF 135) (0.029 g, 0.087 
mmol, 1.0 eq.) was dissolved in 3 mL p.a. DMF in a one necked 10 mL round-bottomed flask. To the 
resulting solution, EDCI (0.018 g, 0.096 mmol, 1.1 eq.) and catalytic amount of DMAP (0.001 mmol, 1 
mol%) was added while stirring at 0 °C. After 15 min, a solution of PG-cNH2 (0.1 g, 0.43 mmol NH2 
group, 20% of which will be functionalized with nicotinic acid moiety) in 1 mL p.a. DMF was added 
drop-wise to the reaction mixture for 30 min. The reaction was allowed to run for 24 h and the 
6-((tert-Butoxycarbonyl(pyridin-2-ylmethyl)amino)methyl)nicotinic acid (NF 135) (0.029 g,
0.087 mmol, 1.0 eq.) was dissolved in 3 mL p.a. DMF in a one necked 10 mL round-bottomed
flask. To the resulting solution, EDCI (0.018 g, 0.096 mmol, 1.1 eq.) and catalytic amount of DMAP
(0.001 mmol, 1 mol%) was added while stirring at 0 ◦C. After 15 min, a solution of PG-cNH2 (0.1 g,
0.43 mmol NH2 group, 20% of which will be functionalized with nicotinic acid moiety) in 1 mL p.a.
DMF was added drop-wise to the reaction mixture for 30 min. The reaction was allowed to run
for 24 h and the temperature was allowed to rise from 0 ◦C to r.t. The solvent was evaporated and
the product was dialyzed in MeOH for 24 h. Yield: 72%; Conversion: quant.; 1H-NMR (500 MHz,
CD3OD): δ (ppm) = 8.41 (1H, aromatic), 7.92–7.70 (3H, aromatic), 7.23–7.51 (3H, aromatic), 4.72–4.51
(functionalized primary PG-groups), 4.20–3.43 (PG-backbone), 2.53–2.22 (4H, -CH2-), 1.37 (3H, CH3)
13C-NMR: (CD3OD): δ (ppm) = 169.2, 150.4, 148.6, 131.8, 119.6, 128.6, 75.1, 29.3; IR (KBr)
−
υ = 3564, 3121,
3002, 1745, 1645, 1599, 1409, 1326, 1089 cm−1.
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4.13. Procedure for the Synthesis of PG-cNH2 Containing 6-(((2-(tert-butoxycarbonyl(pyridin-2-ylmethyl)-
amino)ethyl)(propyl)amino)methyl)nicotinic Acid 12 
 
6-(((2-(tert-Butoxycarbonyl(pyridin-2-ylmethyl)amino)ethyl)(propyl)amino)methyl)nicotinic 
acid (KR 455), (0.050 g, 0.117 mmol, 1.0 eq.) was dissolved in 3 mL p.a. DMF in a one necked 10 mL 
round-bottomed flask. To the resulting solution, EDCI (0.025 g, 0.128 mmol, 1.1 eq.) and catalytic 
amount of DMAP (0.001 mmol, 1 mol%) was added while stirring at 0 °C. After 15 min, a solution of 
PG-cNH2 (0.027 g, 0.117 mmol NH2 group) in 1 mL p.a. DMF was added drop-wise to the reaction 
mixture for 30 min. The reaction was allowed to run for 24 h and the temperature was allowed to rise 
from 0 °C to r.t. The solvent was evaporated and the product was dialyzed in MeOH for 24 h. Yield: 
76%; Conversion: quant.; 1H-NMR (500 MHz, CD3OD): δ (ppm) = 8.77 (bs, 1H, aromatic), 8.43–8.11 
(bs, 3H, aromatic), 7.78–7.62 (bs, 4H, aromatic), 7.12–6.91 (bs, 3H, aromatic), 4.51 (-CH2-NHCO-), 4.01–
3.34 (PG-backbone), 2.45–2.15 (-CH2-NCH2-CH2-), 1.41–1.45 (bs, -CH2 + CH3-, BOC), 0.84 (-CH3) 13C-
NMR: (CD3OD): δ (ppm) = 167.1, 157.4, 153.5, 139.6, 127.8, 124.3, 79.4, 25.6; IR (KBr) ῡ = 3363, 3065, 
3027, 2878, 1698, 1543, 1435, 1276, 1121, 855 cm−1. [An equivalent of 25% of all PG amino groups in the 
core were targeted, the functionalization ended up at ~20% after the reaction]. 
4.14. Procedure for the Synthesis of Maltose Modified PG Amine 14 
 
PG amine (0.25 g, 3.419 mmol NH2 group), D-(+)-maltose monohydrate (12.319 g, 34.189 mmol, 
10.0 eq.), and borane-pyridine complex (4.30 mL, 3.177 g, 34.189 mmol, 10 eq., 8 M solution) were 
dissolved in sodium borate buffer (40.0 mL, 0.1 M) solution. The reaction solution was stirred at 50 
°C for 7 d. The crude product was transferred directly to dialysis tube and purified by dialysis 
towards deionized water for 3 d. Maltose modified PG amine was obtained after freeze drying. Yield: 
65% Conversion: 48% of all glycidol units based on anomeric proton at 5.1 ppm. 1H-NMR (500 MHz, 
6-(((2-(tert-Butoxycarbonyl(pyridin-2-ylmethyl)amino)ethyl)(propyl)amino)methyl)nicotinic acid
(KR 455), (0.050 g, 0.117 mmol, 1.0 eq.) was dissolved in 3 mL p.a. DMF in a one necked 10 L
round-botto ed flask. To the resulting solution, EDCI (0.025 g, 0.128 ol, 1.1 eq.) and catalytic
amount of D AP (0.001 mmol, 1 mol%) was added while stirring at 0 ◦C. After 15 min, a solution of
PG-cNH2 (0.027 g, 0.117 ol NH2 group) in 1 L p.a. D F was added drop-wise to the reaction
mixture for 30 min. The reaction was allowed to run for 24 h and the temperature was allowed to rise
from 0 ◦C to r.t. The solvent was evaporated and the product was dialyzed in eOH for 24 h. Yield:
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76%; Conversion: quant.; 1H-NMR (500 MHz, CD3OD): δ (ppm) = 8.77 (bs, 1H, aromatic), 8.43–8.11 (bs,
3H, aromatic), 7.78–7.62 (bs, 4H, aromatic), 7.12–6.91 (bs, 3H, aromatic), 4.51 (-CH2-NHCO-), 4.01–3.34
(PG-backbone), 2.45–2.15 (-CH2-NCH2-CH2-), 1.41–1.45 (bs, -CH2 + CH3-, BOC), 0.84 (-CH3) 13C-NMR:
(CD3OD): δ (ppm) = 167.1, 157.4, 153.5, 139.6, 127.8, 124.3, 79.4, 25.6; IR (KBr)
−
υ = 3363, 3065, 3027,
2878, 1698, 1543, 1435, 1276, 1121, 855 cm−1. [An equivalent of 25% of all PG amino groups in the core
were targeted, the functionalization ended up at ~20% after the reaction].
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PG-cNH2 (0.027 g, 0.117 mmol NH2 group) in 1 mL p.a. DMF was added drop-wise to the reaction 
mixture for 30 min. The reaction was allowed to run for 24 h and the temperature was allowed to rise 
from 0 °C to r.t. The solvent was evaporated and the product was dialyzed in MeOH for 24 h. Yield: 
76%; Conversion: quant.; 1H-NMR (500 MHz, CD3OD): δ (ppm) = 8.77 (bs, 1H, aromatic), 8.43–8.11 
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3.34 (PG-backbone), 2.45–2.15 (-CH2-NCH2-CH2-), 1.41–1.45 (bs, -CH2 + CH3-, BOC), 0.84 (-CH3) 13C-
NMR: (CD3OD): δ (ppm) = 167.1, 157.4, 153.5, 139.6, 127.8, 124.3, 79.4, 25.6; IR (KBr) ῡ = 3363, 3065, 
3027, 2878, 1698, 1543, 1435, 1276, 1121, 855 cm−1. [An equivalent of 25% of all PG amino groups in the 
core were targeted, the functionalization ended up at ~20% after the reaction]. 
4.14. Procedure for the Synthesis of Maltose Modified PG Amine 14 
 
PG amine (0.25 g, 3.419 mmol NH2 group), D-(+)-maltose monohydrate (12.319 g, 34.189 mmol, 
10.0 eq.), and borane-pyridine complex (4.30 mL, 3.177 g, 34.189 mmol, 10 eq., 8 M solution) were 
dissolved in sodium borate buffer (40.0 mL, 0.1 M) solution. The reaction solution was stirred at 50 
°C for 7 d. The crude product was transferred directly to dialysis tube and purified by dialysis 
towards deionized water for 3 d. Maltose modified PG amine was obtained after freeze drying. Yield: 
65% Conversion: 48% of all glycidol units based on anomeric proton at 5.1 ppm. 1H-NMR (500 MHz, 
PG amine (0.25 g, 3.419 mmol NH2 group), D-(+)-maltose monohydrate (12.319 g, 34.189 mmol,
10.0 eq.), and borane-pyridine complex (4.30 mL, 3.177 g, 34.189 mmol, 10 eq., 8 M solution) were
dissolved in sodium borate buffer (40.0 mL, 0.1 M) solution. The reaction solution was stirred at 50 ◦C
for 7 d. The crude product was transferred directly to dialysis tube and purified by dialysis towards
deionized water for 3 d. Maltose modified PG amine was obtained after freeze drying. Yield: 65%
Conversion: 48% of all glycidol units based on anomeric proton at 5.1 ppm. 1H-NMR (500 MHz, D2O):
δ (ppm) = 5.10–5.33 (bs, 1H, Sugar), 4.42–2.56 (PG-backbone + Sugar); 13C-NMR: (D2O): δ (ppm) = 100.4
(C-1), 81.7 (C-4), 75.8–69.3 (PG-backbone + C-maltose), 62.7–62.2 (6-C), 60.3 (6-C).
4.15. Procedure for the Synthesis of N-Acetylglucosamine Modified PG Amine 15
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D2O): δ (ppm) = 5.10–5.33 (bs, 1H, Sugar), 4.42–2.56 (PG-backbone + Sugar); 13C-NMR: (D2O): δ (ppm) 
= 100.4 (C-1), 81.  (C-4́)75.8–69.3 (PG-backbone + C-maltose), 6 .7–62.2 (6-Ć́́), 60.3 (6-C). 
4.15. Procedure for the Synthesis of N-Acetylglucosamine Modified PG Amine 15 
 
PG amine (0.25 g, 3.419 mmol NH2 group), N-acetylglucosamine (12.319 g, 34.189 mmol, 10.0 
eq.), and borane-pyridine complex (4.30 mL, 3.177 g, 34.189 mmol, 10 eq., 8 M solution) were 
dissolved in sodium borate buffer (40.0 mL, 0.1 M) solution. The reaction solution was stirred at 50 
°C for 7 days. The crude yellow colored solution was transferred directly to dialysis tube and purified 
by dialysis towards acidified water for 3 days. N-acetylglucosamine modified PG amine was obtained 
after freeze drying. Yield: 58%; Conversion 54% of all glycidol units; 1H-NMR (500 MHz, D2O): δ 
(ppm) = 4.51–3.23 (PG-backbone + hexose unit); 2.23–1.85 (bs, -CH3-); 13C-NMR: (D2O): δ (ppm) = 168.7 
(C = O), 74.7–60.8 (PG-groups + Sugar unit), 58.7 (C-5), 53.2 (6-Ć), 48.7 (-CH2NH-), 21.9 (-CH3). 
4.16. Procedure for the Synthesis of Polyglycerolamine Containing N-α-BOC-Histidine 16 
 
N-α-BOC histidine (0.035 g, 0.136 mmol, 1.0 eq.) was dissolved in 2 mL p.a. DMF in a one necked 
10 mL round-bottomed flask. To the resulting solution, EDCI (0.029 g, 0.150 mmol, 1.1 eq.) and 
catalytic amount of DMAP (0.001 mmol, 1 mol%) was added while stirring at 0 °C. After 15 min, a 
solution of PG amine (0.1 g, 0.68 mmol NH2 group, 20% of which will be functionalized with histidine 
moiety) in 2 mL p.a DMF:water (3:1) was added drop-wise to the reaction mixture for 30 min. The 
reaction was allowed to run for 24 h and the temperature was allowed to rise from 0 °C to r.t. The 
solvent was evaporated and the product was dialyzed in MeOH for 24 h. Yield: 70%; Conversion: 
quant. 1H-NMR (500 MHz, CD3OD): δ (ppm) = 7.62 (bs, 1H, imidazole ring), 6.91 (bs, 1H, imidazole 
ring), 4.42–3.97 (functionalized PG-groups), 3.95–3.41 (PG-backbone), 3.07 (bs, 1H, -CH-), 2.88 (2H, -
CH2-), 1.49 (bs, 3H, -CH3); 13C-NMR: (CD3OD): δ (ppm) = 160.8, 154.6, 143.5, 129.8, 124.3, 29.7; IR (KBr) 
ῡ = 2982, 2769, 1745, 1612, 1587,1523, 1434, 1369, 1275 cm−1. 
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N-α-BOC histidine (0.035 g, 0.136 mmol, 1.0 eq.) was dissolved in 2 mL p.a. DMF in a one necked 
10 mL round-bottomed flask. To the resulting solution, EDCI (0.029 g, 0.150 mmol, 1.1 eq.) and 
catalytic amount of DMAP (0.001 mmol, 1 mol%) was added while stirring at 0 °C. After 15 min, a 
solution of PG amine (0.1 g, 0.68 mmol NH2 group, 20% of which will be functionalized with histidine 
moiety) in 2 mL p.a DMF:water (3:1) was added drop-wise to the reaction mixture for 30 min. The 
reaction was allowed to run for 24 h and the temperature was allowed to rise from 0 °C to r.t. The 
solvent was evaporated and the product was dialyzed in MeOH for 24 h. Yield: 70%; Conversion: 
quant. 1H-NMR (500 MHz, CD3OD): δ (ppm) = 7.62 (bs, 1H, imidazole ring), 6.91 (bs, 1H, imidazole 
ring), 4.42–3.97 (functionalized PG-groups), 3.95–3.41 (PG-backbone), 3.07 (bs, 1H, -CH-), 2.88 (2H, -
CH2-), 1.49 (bs, 3H, -CH3); 13C-NMR: (CD3OD): δ (ppm) = 160.8, 154.6, 143.5, 129.8, 124.3, 29.7; IR (KBr) 
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N-α-BOC histidine (0.035 g, 0.136 mmol, 1.0 eq.) was dissolved in 2 mL p.a. DMF in a one necked
10 mL round-bottomed flask. To the resulting solution, EDCI (0.029 g, 0.150 mmol, 1.1 eq.) and catalytic
amount of DMAP (0.001 mmol, 1 mol%) was added while stirring at 0 ◦C. After 15 min, a solution of
PG amine (0.1 g, 0.68 mmol NH2 group, 20% of which will be functionalized with histidine moiety)
in 2 mL p.a DMF:water (3:1) was added drop-wise to the reaction mixture for 30 min. The reaction
was allowed to run for 24 h and the temperature was allowed to rise from 0 ◦C to r.t. The solvent
was evaporated and the product was dialyzed in MeOH for 24 h. Yield: 70%; Conversion: quant.
1H-NMR (500 MHz, CD3OD): δ (ppm) = 7.62 (bs, 1H, imidazole ring), 6.91 (bs, 1H, imidazole ring),
4.42–3.97 (functionalized PG-groups), 3.95–3.41 (PG-backbone), 3.07 (bs, 1H, -CH-), 2.88 (2H, -CH2-),
1.49 (bs, 3H, -CH3); 13C-NMR: (CD3OD): δ (ppm) = 160.8, 154.6, 143.5, 129.8, 124.3, 29.7; IR (KBr)
−
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